Valuation of the EQ-5D-5L in Taiwan

Objectives To date, a value set for the EQ-5D-5L based on the health state preferences of the general Taiwanese population has not been available. This study aimed to develop a Taiwanese value set for EQ-5D-5L to facilitate health technology assessment for medical products and services. Methods An international standardized protocol for EQ-5D-5L valuation studies developed by the EuroQol group was adopted. Adult members of the general public were recruited from six geographic regions in Taiwan. In computer-based face-to-face interviews, each participant completed 10 composite time trade-off (C-TTO) tasks and 7 discrete choice experiment (DCE) tasks. The C-TTO and DCE data were modeled alone or in combination (using hybrid models) with additive models containing 20 dummy variables as main effects. The model performance was assessed both quantitatively and qualitatively (mainly logical consistency and prediction patterns). Results Of 1,073 recruited participants, 1,000 completed the study. Approximately 13% of observed utility values were -1 in the C-TTO tasks. The hybrid model, using all available data that assumed C-TTO response values left-censored at -1 and with main effects coefficients with logical consistency (monotonicity), was considered as the most appropriate model. The predicted utility ranged from -1.0259 to 1. Conclusions An EQ-5D-5L value set was developed for Taiwan using an established study protocol and a representative sample of the general population. This may facilitate health economic evaluations and decision making on resource allocation under Taiwan’s national health insurance program in the future.

[1]  Mark Oppe,et al.  A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[2]  N. Bansback,et al.  A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada , 2015, Medical care.

[3]  Azeem Majeed,et al.  An overview of the healthcare system in Taiwan , 2010, London journal of primary care.

[4]  Hsin-Yi Lee,et al.  Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan. , 2013, Journal of the Formosan Medical Association = Taiwan yi zhi.

[5]  J. Brazier,et al.  A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

[6]  Pirjo Räsänen,et al.  Effect of health-related quality-of-life instrument and quality-adjusted life year calculation method on the number of life years gained in the critical care setting. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[7]  Mark Oppe,et al.  Introducing the composite time trade-off: a test of feasibility and face validity , 2013, The European Journal of Health Economics.

[8]  Nan Luo,et al.  Estimating an EQ-5D-5L Value Set for China. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[9]  L. Sharples,et al.  Problems and solutions in calculating quality-adjusted life years (QALYs) , 2003, Health and quality of life outcomes.

[10]  Brendan Mulhern,et al.  Valuing health‐related quality of life: An EQ‐5D‐5L value set for England , 2017, Health economics.

[11]  Michael Herdman,et al.  Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states , 2013, The European Journal of Health Economics.

[12]  Mark Oppe,et al.  Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[13]  R. Rabin,et al.  EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.

[14]  Takashi Fukuda,et al.  Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[15]  G Ardine de Wit,et al.  Dutch Tariff for the Five-Level Version of EQ-5D. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[16]  Chung-Liang Lai,et al.  Post-acute care for stroke – a retrospective cohort study in Taiwan , 2017, Patient preference and adherence.

[17]  Nan Luo,et al.  The EQ-5D-5L valuation study in Korea , 2016, Quality of Life Research.

[18]  Mark Oppe,et al.  EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes , 2016, PharmacoEconomics.

[19]  Takashi Fukuda,et al.  Developing a Japanese version of the EQ-5D-5L value set , 2015 .

[20]  Jan Passchier,et al.  The Indonesian EQ-5D-5L Value Set , 2017, PharmacoEconomics.

[21]  Juan Manuel Ramos-Goñi,et al.  Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong , 2017, The Patient - Patient-Centered Outcomes Research.

[22]  Mark Oppe,et al.  Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach , 2014, Medical care.

[23]  Michael Herdman,et al.  Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach , 2012, Quality of Life Research.

[24]  Mark Oppe,et al.  Quality Control Process for EQ-5D-5L Valuation Studies. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[25]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.